Intracellular Breakable and Ultrasound-Responsive Hybrid Microsized Containers for Selective Drug Release into Cancerous Cells

Alexander S. Timin, Albert R. Muslimov, Kirill V. Lepik, Maria V. Okilova, Nikolai Y. Tcvetkov, Alena I. Shakirova, Boris V. Afanasyev, Dmitry A. Gorin, Gleb B. Sukhorukov

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

This work reports an efficient and straightforward strategy to fabricate hybrid microsized containers with reduction-sensitive and ultrasound-responsive properties. The ultrasound and reductive sensitivity are visualized using scanning electron microscopy, with the results showing structural decomposition upon ultrasound irradiation and in the presence of reducing agent. The ultrasound-responsive functionalities of hybrid carriers can be used as external trigger for rapid controlled release, while prolonged drug release can be achieved in the presence of reducing agent. To evaluate the potential for targeted drug delivery, hybrid microsized containers are loaded with the anticancer drug doxorubicin (Dox). Such hybrid capsules can undergo structural intracellular degradation after cellular uptake by human cervical cancer cell line (HeLa), resulting in Dox release into cancer cells. In contrast, there is no Dox release when hybrid capsules are incubated with human mesenchymal stem cells (MSCs) as an example of normal human cells. The cell viability results indicate that Dox-loaded capsules effectively killed HeLa cells, while they have lower cytotoxicity against MSCs as an example of healthy cells. Thus, the newly developed intracellular- and ultrasound-responsive microcarriers obtained via sol-gel method and layer-by-layer technique provide a high therapeutic efficacy for cancer, while minimizing adverse side effect.

Original languageEnglish
Article number1600417
JournalParticle and Particle Systems Characterization
Volume34
Issue number5
DOIs
Publication statusAccepted/In press - 2017

Fingerprint

capsules
containers
Containers
drugs
stem cells
Ultrasonics
cancer
Doxorubicin
Cells
Capsules
cells
Pharmaceutical Preparations
Reducing Agents
Reducing agents
Stem cells
cultured cells
viability
delivery
actuators
gels

Keywords

  • Cancer therapy
  • Intracellular degradation
  • Multiresponsive triggering
  • Polyelectrolyte capsules
  • Sol-gel methods
  • Ultrasound

ASJC Scopus subject areas

  • Chemistry(all)
  • Materials Science(all)
  • Condensed Matter Physics

Cite this

Intracellular Breakable and Ultrasound-Responsive Hybrid Microsized Containers for Selective Drug Release into Cancerous Cells. / Timin, Alexander S.; Muslimov, Albert R.; Lepik, Kirill V.; Okilova, Maria V.; Tcvetkov, Nikolai Y.; Shakirova, Alena I.; Afanasyev, Boris V.; Gorin, Dmitry A.; Sukhorukov, Gleb B.

In: Particle and Particle Systems Characterization, Vol. 34, No. 5, 1600417, 2017.

Research output: Contribution to journalArticle

Timin, Alexander S. ; Muslimov, Albert R. ; Lepik, Kirill V. ; Okilova, Maria V. ; Tcvetkov, Nikolai Y. ; Shakirova, Alena I. ; Afanasyev, Boris V. ; Gorin, Dmitry A. ; Sukhorukov, Gleb B. / Intracellular Breakable and Ultrasound-Responsive Hybrid Microsized Containers for Selective Drug Release into Cancerous Cells. In: Particle and Particle Systems Characterization. 2017 ; Vol. 34, No. 5.
@article{1cfef28a0f094a87b4ed364f884b8bc3,
title = "Intracellular Breakable and Ultrasound-Responsive Hybrid Microsized Containers for Selective Drug Release into Cancerous Cells",
abstract = "This work reports an efficient and straightforward strategy to fabricate hybrid microsized containers with reduction-sensitive and ultrasound-responsive properties. The ultrasound and reductive sensitivity are visualized using scanning electron microscopy, with the results showing structural decomposition upon ultrasound irradiation and in the presence of reducing agent. The ultrasound-responsive functionalities of hybrid carriers can be used as external trigger for rapid controlled release, while prolonged drug release can be achieved in the presence of reducing agent. To evaluate the potential for targeted drug delivery, hybrid microsized containers are loaded with the anticancer drug doxorubicin (Dox). Such hybrid capsules can undergo structural intracellular degradation after cellular uptake by human cervical cancer cell line (HeLa), resulting in Dox release into cancer cells. In contrast, there is no Dox release when hybrid capsules are incubated with human mesenchymal stem cells (MSCs) as an example of normal human cells. The cell viability results indicate that Dox-loaded capsules effectively killed HeLa cells, while they have lower cytotoxicity against MSCs as an example of healthy cells. Thus, the newly developed intracellular- and ultrasound-responsive microcarriers obtained via sol-gel method and layer-by-layer technique provide a high therapeutic efficacy for cancer, while minimizing adverse side effect.",
keywords = "Cancer therapy, Intracellular degradation, Multiresponsive triggering, Polyelectrolyte capsules, Sol-gel methods, Ultrasound",
author = "Timin, {Alexander S.} and Muslimov, {Albert R.} and Lepik, {Kirill V.} and Okilova, {Maria V.} and Tcvetkov, {Nikolai Y.} and Shakirova, {Alena I.} and Afanasyev, {Boris V.} and Gorin, {Dmitry A.} and Sukhorukov, {Gleb B.}",
year = "2017",
doi = "10.1002/ppsc.201600417",
language = "English",
volume = "34",
journal = "Particle and Particle Systems Characterization",
issn = "0934-0866",
publisher = "Wiley-VCH Verlag",
number = "5",

}

TY - JOUR

T1 - Intracellular Breakable and Ultrasound-Responsive Hybrid Microsized Containers for Selective Drug Release into Cancerous Cells

AU - Timin, Alexander S.

AU - Muslimov, Albert R.

AU - Lepik, Kirill V.

AU - Okilova, Maria V.

AU - Tcvetkov, Nikolai Y.

AU - Shakirova, Alena I.

AU - Afanasyev, Boris V.

AU - Gorin, Dmitry A.

AU - Sukhorukov, Gleb B.

PY - 2017

Y1 - 2017

N2 - This work reports an efficient and straightforward strategy to fabricate hybrid microsized containers with reduction-sensitive and ultrasound-responsive properties. The ultrasound and reductive sensitivity are visualized using scanning electron microscopy, with the results showing structural decomposition upon ultrasound irradiation and in the presence of reducing agent. The ultrasound-responsive functionalities of hybrid carriers can be used as external trigger for rapid controlled release, while prolonged drug release can be achieved in the presence of reducing agent. To evaluate the potential for targeted drug delivery, hybrid microsized containers are loaded with the anticancer drug doxorubicin (Dox). Such hybrid capsules can undergo structural intracellular degradation after cellular uptake by human cervical cancer cell line (HeLa), resulting in Dox release into cancer cells. In contrast, there is no Dox release when hybrid capsules are incubated with human mesenchymal stem cells (MSCs) as an example of normal human cells. The cell viability results indicate that Dox-loaded capsules effectively killed HeLa cells, while they have lower cytotoxicity against MSCs as an example of healthy cells. Thus, the newly developed intracellular- and ultrasound-responsive microcarriers obtained via sol-gel method and layer-by-layer technique provide a high therapeutic efficacy for cancer, while minimizing adverse side effect.

AB - This work reports an efficient and straightforward strategy to fabricate hybrid microsized containers with reduction-sensitive and ultrasound-responsive properties. The ultrasound and reductive sensitivity are visualized using scanning electron microscopy, with the results showing structural decomposition upon ultrasound irradiation and in the presence of reducing agent. The ultrasound-responsive functionalities of hybrid carriers can be used as external trigger for rapid controlled release, while prolonged drug release can be achieved in the presence of reducing agent. To evaluate the potential for targeted drug delivery, hybrid microsized containers are loaded with the anticancer drug doxorubicin (Dox). Such hybrid capsules can undergo structural intracellular degradation after cellular uptake by human cervical cancer cell line (HeLa), resulting in Dox release into cancer cells. In contrast, there is no Dox release when hybrid capsules are incubated with human mesenchymal stem cells (MSCs) as an example of normal human cells. The cell viability results indicate that Dox-loaded capsules effectively killed HeLa cells, while they have lower cytotoxicity against MSCs as an example of healthy cells. Thus, the newly developed intracellular- and ultrasound-responsive microcarriers obtained via sol-gel method and layer-by-layer technique provide a high therapeutic efficacy for cancer, while minimizing adverse side effect.

KW - Cancer therapy

KW - Intracellular degradation

KW - Multiresponsive triggering

KW - Polyelectrolyte capsules

KW - Sol-gel methods

KW - Ultrasound

UR - http://www.scopus.com/inward/record.url?scp=85014472683&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85014472683&partnerID=8YFLogxK

U2 - 10.1002/ppsc.201600417

DO - 10.1002/ppsc.201600417

M3 - Article

VL - 34

JO - Particle and Particle Systems Characterization

JF - Particle and Particle Systems Characterization

SN - 0934-0866

IS - 5

M1 - 1600417

ER -